Previous close | 0.0550 |
Open | 0.0587 |
Bid | 0.0517 x 0 |
Ask | 0.0579 x 0 |
Day's range | 0.0540 - 0.0587 |
52-week range | 0.0190 - 0.4200 |
Volume | |
Avg. volume | 440,854 |
Market cap | 3.992M |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
LAGUNA HILLS, Calif., October 09, 2024--Sonendo, Inc. (OTCQX: SONX) ("Sonendo" or "Company"), a leading dental technology company and developer of the GentleWave® System, today announced that the Company has entered into an Asset Purchase Agreement ("APA") with Biolase, Inc. and certain of its subsidiaries (the "Sellers") pursuant to which the Company agreed to acquire substantially all of the assets of the Sellers and their subsidiaries for a total purchase price of $14 million, plus the assump
LAGUNA HILLS, Calif., August 07, 2024--Sonendo, Inc. ("Sonendo" or the "Company") (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the second quarter ended June 30, 2024.
LAGUNA HILLS, Calif., July 24, 2024--Sonendo, Inc. ("Sonendo") (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the second quarter 2024 after the market close on Wednesday, August 7th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results.